Omeros Corporation (OMER)
USD 7.25
(-1.49%)
USD 7.25
(-1.49%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 329.7 Million USD | 35.5% |
| 2022 | 243.33 Million USD | -28.97% |
| 2021 | 342.58 Million USD | 952.42% |
| 2020 | 32.55 Million USD | -9.13% |
| 2019 | 35.82 Million USD | -76.21% |
| 2018 | 150.55 Million USD | 78.99% |
| 2017 | 84.11 Million USD | 5.79% |
| 2016 | 79.51 Million USD | 59.76% |
| 2015 | 49.76 Million USD | 89.5% |
| 2014 | 26.26 Million USD | 76.29% |
| 2013 | 14.89 Million USD | -25.89% |
| 2012 | 20.1 Million USD | 48.35% |
| 2011 | 13.55 Million USD | 44.78% |
| 2010 | 9.36 Million USD | 19.59% |
| 2009 | 7.82 Million USD | 6533.05% |
| 2008 | 118 Thousand USD | 0.0% |
| 2007 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 430.92 Million USD | 30.7% |
| 2024 Q2 | 403.71 Million USD | -6.31% |
| 2023 Q3 | 241.07 Million USD | -0.36% |
| 2023 Q4 | 329.7 Million USD | 36.76% |
| 2023 Q1 | 242.49 Million USD | -0.34% |
| 2023 FY | 329.7 Million USD | 35.5% |
| 2023 Q2 | 241.93 Million USD | -0.23% |
| 2022 Q2 | 338.87 Million USD | 0.2% |
| 2022 Q3 | 338.35 Million USD | -0.16% |
| 2022 Q4 | 243.33 Million USD | -28.08% |
| 2022 FY | 243.33 Million USD | -28.97% |
| 2022 Q1 | 338.2 Million USD | -1.28% |
| 2021 Q2 | 343.99 Million USD | 1.18% |
| 2021 FY | 342.58 Million USD | 952.42% |
| 2021 Q4 | 342.58 Million USD | -0.21% |
| 2021 Q3 | 343.3 Million USD | -0.2% |
| 2021 Q1 | 339.96 Million USD | 944.38% |
| 2020 Q2 | 193.91 Million USD | 0.92% |
| 2020 Q3 | 262.52 Million USD | 35.38% |
| 2020 FY | 32.55 Million USD | -9.13% |
| 2020 Q4 | 32.55 Million USD | -87.6% |
| 2020 Q1 | 192.14 Million USD | 436.38% |
| 2019 Q1 | 177.76 Million USD | 18.07% |
| 2019 FY | 35.82 Million USD | -76.21% |
| 2019 Q4 | 35.82 Million USD | 12.97% |
| 2019 Q3 | 31.7 Million USD | -82.32% |
| 2019 Q2 | 179.36 Million USD | 0.9% |
| 2018 Q2 | 129.75 Million USD | 52.58% |
| 2018 Q1 | 85.03 Million USD | 1.09% |
| 2018 FY | 150.55 Million USD | 78.99% |
| 2018 Q4 | 150.55 Million USD | 14.32% |
| 2018 Q3 | 131.69 Million USD | 1.5% |
| 2017 Q3 | 82.77 Million USD | 1.55% |
| 2017 Q2 | 81.51 Million USD | 1.25% |
| 2017 Q1 | 80.5 Million USD | 1.25% |
| 2017 FY | 84.11 Million USD | 5.79% |
| 2017 Q4 | 84.11 Million USD | 1.62% |
| 2016 Q3 | 70.28 Million USD | 0.65% |
| 2016 Q1 | 49.97 Million USD | 0.41% |
| 2016 FY | 79.51 Million USD | 59.76% |
| 2016 Q4 | 79.51 Million USD | 13.12% |
| 2016 Q2 | 69.83 Million USD | 39.74% |
| 2015 Q1 | 23.9 Million USD | -8.97% |
| 2015 FY | 49.76 Million USD | 89.5% |
| 2015 Q4 | 49.76 Million USD | 162.3% |
| 2015 Q3 | 18.97 Million USD | -11.65% |
| 2015 Q2 | 21.47 Million USD | -10.16% |
| 2014 FY | 26.26 Million USD | 76.29% |
| 2014 Q4 | 26.26 Million USD | -8.01% |
| 2014 Q3 | 28.55 Million USD | -7.18% |
| 2014 Q2 | 30.76 Million USD | -4.5% |
| 2014 Q1 | 32.21 Million USD | 116.22% |
| 2013 FY | 14.89 Million USD | -25.89% |
| 2013 Q4 | 14.89 Million USD | -9.03% |
| 2013 Q2 | 17.8 Million USD | -7.24% |
| 2013 Q1 | 19.2 Million USD | -4.49% |
| 2013 Q3 | 16.37 Million USD | -8.05% |
| 2012 Q3 | 8.67 Million USD | -16.1% |
| 2012 FY | 20.1 Million USD | 48.35% |
| 2012 Q2 | 10.34 Million USD | -13.57% |
| 2012 Q4 | 20.1 Million USD | 131.63% |
| 2012 Q1 | 11.96 Million USD | -11.67% |
| 2011 Q4 | 13.55 Million USD | -10.21% |
| 2011 FY | 13.55 Million USD | 44.78% |
| 2011 Q3 | 15.09 Million USD | -9.05% |
| 2011 Q2 | 16.59 Million USD | -8.11% |
| 2011 Q1 | 18.05 Million USD | 92.93% |
| 2010 Q4 | 9.36 Million USD | 5.49% |
| 2010 Q2 | 4.87 Million USD | -23.56% |
| 2010 FY | 9.36 Million USD | 19.59% |
| 2010 Q1 | 6.37 Million USD | -18.54% |
| 2010 Q3 | 8.87 Million USD | 82.05% |
| 2009 FY | 7.82 Million USD | 6533.05% |
| 2009 Q4 | 7.82 Million USD | -15.33% |
| 2009 Q3 | 9.24 Million USD | 9734.04% |
| 2009 Q2 | 94 Thousand USD | 0.0% |
| 2008 Q4 | 118 Thousand USD | 0.0% |
| 2008 FY | 118 Thousand USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -362.926% |
| Alkermes plc | 287.73 Million USD | -14.588% |
| Agenus Inc. | 137.32 Million USD | -140.093% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 85.928% |
| Aptorum Group Limited | 3.05 Million USD | -10679.957% |
| Ardelyx, Inc. | 51.54 Million USD | -539.62% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -215.181% |
| Bicycle Therapeutics plc | 40.08 Million USD | -722.617% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -227.745% |
| ChromaDex Corporation | 2.57 Million USD | -12704.078% |
| Chimerix, Inc. | 125 Thousand USD | -263664.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -10080.382% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -1172.599% |
| CRISPR Therapeutics AG | 223 Million USD | -47.845% |
| Precision BioSciences, Inc. | 7.72 Million USD | -4169.131% |
| Dyadic International, Inc. | 88.87 Thousand USD | -370896.962% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -1498559.091% |
| Fortress Biotech, Inc. | 60.85 Million USD | -441.779% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -536040.562% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -8574.165% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -365734.85% |
| Incyte Corporation | 29.16 Million USD | -1030.598% |
| IO Biotech, Inc. | 1.83 Million USD | -17828.494% |
| Jaguar Health, Inc. | 30.99 Million USD | -963.805% |
| Novavax, Inc. | 168.01 Million USD | -96.234% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -1331.944% |
| Opthea Limited | 200.53 Million USD | -64.412% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -5629.018% |
| ContextLogic Inc. | 6 Million USD | -5395.083% |
| MiMedx Group, Inc. | 48.09 Million USD | -585.472% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -1540.405% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -860950.9% |
| NextCure, Inc. | 5.94 Million USD | -5442.192% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -227282.759% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -1391.136% |
| PDS Biotechnology Corporation | 19.5 Million USD | -1590.259% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -185.508% |
| Pharming Group N.V. | 166.1 Million USD | -98.492% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -5206.696% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -883.754% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -27238.723% |
| Acelyrin, Inc. | 1.19 Million USD | -27513.484% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -71575.0% |
| Summit Therapeutics Inc. | 103.29 Million USD | -219.203% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -8647.811% |
| Senti Biosciences, Inc. | 33.53 Million USD | -883.079% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -6807.71% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -854.118% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -446.584% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -20900.318% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -1197.847% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -215.997% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -44941.667% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -2846.162% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -138.392% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -2353.345% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -2098.033% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -72.682% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -526.125% |
| Fortress Biotech, Inc. | 60.85 Million USD | -441.779% |
| Precigen, Inc. | 5.89 Million USD | -5492.96% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -685.236% |
| AlloVir, Inc. | 16.64 Million USD | -1880.448% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -401.399% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -238.645% |
| ImmuCell Corporation | 10.54 Million USD | -3027.984% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -29207.111% |
| Onconetix, Inc. | 118.85 Thousand USD | -277296.367% |
| PureTech Health plc | 18.25 Million USD | -1706.603% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -332935.354% |
| Elevation Oncology, Inc. | 30.13 Million USD | -994.021% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -1169.854% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -669.009% |
| Innoviva, Inc. | 446.23 Million USD | 26.114% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -39480.432% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -493145.467% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -59.302% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -363.095% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -10242.064% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -31663.487% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -1376.776% |
| Aptose Biosciences Inc. | 621 Thousand USD | -52992.593% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -32513.9% |
| Century Therapeutics, Inc. | 46.65 Million USD | -606.642% |
| Kura Oncology, Inc. | 9.33 Million USD | -3433.058% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -1134.85% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -238816.667% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -3413.106% |
| Autolus Therapeutics plc | 47.91 Million USD | -588.118% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -6620.444% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -4767.931% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -152.338% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -3967.921% |
| IGM Biosciences, Inc. | 34.67 Million USD | -850.926% |
| INmune Bio, Inc. | 397 Thousand USD | -82949.118% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -89.755% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -8032.31% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -224266.957% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -562.431% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -504.187% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -621.566% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 30.349% |
| Verastem, Inc. | 40.08 Million USD | -722.494% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -7389.891% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -3179.342% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -4925.225% |
| Histogen Inc. | 4.38 Million USD | -7420.643% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -37281.519% |
| Organovo Holdings, Inc. | 888 Thousand USD | -37028.941% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -999.017% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -7761.35% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -1644.933% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -335.542% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -354025.494% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -1172.648% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -123385.019% |
| Amarin Corporation plc | 8.73 Million USD | -3673.664% |
| Mesoblast Limited | 100.48 Million USD | -228.12% |
| Turnstone Biologics Corp. | 1.18 Million USD | -27629.605% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -320.923% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -302381.651% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -302.035% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -73.58% |
| Better Therapeutics, Inc. | 10.34 Million USD | -3086.171% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -1325.751% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -254.396% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -25418.963% |
| Gritstone bio, Inc. | 40.14 Million USD | -721.306% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -18075.579% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -114.661% |
| Insmed Incorporated | 1.19 Billion USD | 72.372% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -5092.205% |
| OmniAb, Inc. | 22.07 Million USD | -1393.567% |
| Alector, Inc. | 30.45 Million USD | -982.562% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -224.692% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -3997.241% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 22.712% |
| Aura Biosciences, Inc. | 16.87 Million USD | -1854.386% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -479.508% |
| Immunic, Inc. | 639 Thousand USD | -51497.027% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -1005.688% |
| Veracyte, Inc. | 7.52 Million USD | -4281.462% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 48.872% |
| FibroGen, Inc. | 89.69 Million USD | -267.576% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -7502.144% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -251846.692% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 93.545% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -890994.595% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -16551.768% |
| TG Therapeutics, Inc. | 100.11 Million USD | -229.316% |
| Galecto, Inc. | 66 Thousand USD | -499453.03% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -242330.147% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 79.802% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -5381.38% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -6009.042% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -18075.579% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -1437.301% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -801.942% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -63672.727% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -628.855% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -978.384% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -635.916% |
| Vaxxinity, Inc. | 13.26 Million USD | -2386.088% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 59.359% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -73322.291% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -3651.337% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 87.802% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -104237.025% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -7295.805% |
| Ainos, Inc. | 5.92 Million USD | -5467.878% |
| Pluri Inc. | 29.05 Million USD | -1034.84% |
| Prothena Corporation plc | 10.72 Million USD | -2975.319% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -1560.899% |
| Celularity Inc. | 26.17 Million USD | -1159.522% |
| Rallybio Corporation | 173 Thousand USD | -190480.925% |
| Cue Biopharma, Inc. | 4.2 Million USD | -7746.383% |
| MeiraGTx Holdings plc | 72.11 Million USD | -357.168% |
| Humacyte, Inc. | 38.6 Million USD | -754.158% |
| Immunocore Holdings plc | 82.64 Million USD | -298.946% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -20340.484% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -9117.361% |
| Blueprint Medicines Corporation | 610.96 Million USD | 46.035% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -22513.512% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -246.369% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -577.235% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -262.708% |
| Pulmatrix, Inc. | 8.32 Million USD | -3859.469% |
| Elicio Therapeutics, Inc. | 6 Million USD | -5388.68% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -2446.968% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -240.791% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -70199.574% |
| Cytokinetics, Incorporated | 607.37 Million USD | 45.716% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -3693.201% |
| Nutriband Inc. | 79.82 Thousand USD | -412929.589% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -7252.921% |
| Vor Biopharma Inc. | 31.83 Million USD | -935.831% |
| Roivant Sciences Ltd. | 477.85 Million USD | 31.003% |
| Evogene Ltd. | 10.65 Million USD | -2994.95% |
| ProKidney Corp. | 3.61 Million USD | -9033.102% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -43339.394% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -1252293.071% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 81.005% |
| CorMedix Inc. | 517.01 Thousand USD | -63671.124% |
| BioLineRx Ltd. | 6.62 Million USD | -4874.427% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -795.013% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -359.577% |
| Atai Life Sciences N.V. | 15.21 Million USD | -2067.543% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -39039.281% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -129196.078% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -664.09% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -80186.612% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -23983.638% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -49621.836% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -85.155% |
| Biomea Fusion, Inc. | 7.83 Million USD | -4110.792% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -16.006% |
| Mereo BioPharma Group plc | 5.3 Million USD | -6120.849% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -15235.116% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -55972.279% |
| Absci Corporation | 4.66 Million USD | -6975.215% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -2761.526% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -1352.765% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -3195.402% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -2765.754% |
| Allakos Inc. | 38.21 Million USD | -762.763% |
| Imunon, Inc. | 1.13 Million USD | -28839.439% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -3720.895% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -39338.397% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -3296950.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -273.197% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -6901.593% |
| XOMA Corporation | 118.51 Million USD | -178.19% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -3174.456% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -789.196% |
| aTyr Pharma, Inc. | 13.76 Million USD | -2294.894% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -4074.009% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -1220.722% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -1531.799% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -2197933.333% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -118417.919% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -2180.929% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 78.009% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -242022.153% |
| UroGen Pharma Ltd. | 98.55 Million USD | -234.553% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -121.109% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -1629.192% |
| Entera Bio Ltd. | 256 Thousand USD | -128691.016% |
| GH Research PLC | 631 Thousand USD | -52151.189% |
| Lisata Therapeutics, Inc. | 137.00 USD | -240660483.942% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -51255.919% |
| Xencor, Inc. | 14.64 Million USD | -2151.776% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -219336.144% |
| Replimune Group, Inc. | 71.99 Million USD | -357.987% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -219703.333% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -4606.038% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -242022.153% |
| Portage Biotech Inc. | 7000.00 USD | -4709971.429% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -49621.836% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -22972.428% |
| OncoCyte Corporation | 2.2 Million USD | -14859.392% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -492695.755% |
| Purple Biotech Ltd. | 163 Thousand USD | -202173.006% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -12906.114% |
| scPharmaceuticals Inc. | 38.81 Million USD | -749.514% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -1206.073% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -451550.685% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -17693.038% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -1151.347% |
| Curis, Inc. | 1.48 Million USD | -22042.713% |
| Daré Bioscience, Inc. | 3.91 Million USD | -8324.433% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -47154.968% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -5494983.333% |
| BeiGene, Ltd. | 197.61 Million USD | -66.84% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -36071.695% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -309.19% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -535.404% |
| bluebird bio, Inc. | 224.41 Million USD | -46.915% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 44.409% |
| DBV Technologies S.A. | 4.52 Million USD | -7184.688% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -24504.851% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -3284.367% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -8652.456% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 12.606% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -668.955% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -19102.388% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -35428.556% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -1787.588% |
| MacroGenics, Inc. | 30.19 Million USD | -991.883% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -1762.424% |
| Prime Medicine, Inc. | 4.35 Million USD | -7467.248% |
| Aditxt, Inc. | 1.04 Million USD | -31549.33% |
| Adagene Inc. | 13.54 Million USD | -2335.038% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -2300.124% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 36.437% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -1828.889% |
| SciSparc Ltd. | 24 Thousand USD | -1373670.833% |
| Vericel Corporation | 81.85 Million USD | -302.787% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -301.997% |
| Generation Bio Co. | 89.77 Million USD | -267.261% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -1386.162% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -63.383% |
| Invivyd, Inc. | 722 Thousand USD | -45565.512% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -579.776% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -11276762.091% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -8519.739% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -1433400.0% |
| 2seventy bio, Inc. | 244.01 Million USD | -35.118% |
| ADMA Biologics, Inc. | 130.59 Million USD | -152.466% |
| Clene Inc. | 7.15 Million USD | -4509.969% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -9665.394% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -33.151% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -29845.958% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -125327.501% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -71.169% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -1060.81% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -3320.531% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -195.241% |
| Evaxion Biotech A/S | 8.48 Million USD | -3784.023% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -340.047% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -409.472% |
| Trevena, Inc. | 35.23 Million USD | -835.785% |
| Surrozen, Inc. | 882 Thousand USD | -37281.519% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -5204.134% |
| Cingulate Inc. | 135.09 Thousand USD | -243946.958% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -1300.675% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -589.759% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -183069.444% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -1199.125% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -1790.836% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -35124.893% |
| Statera Biopharma, Inc. | 11.43 Million USD | -2784.271% |
| ImmunityBio, Inc. | 836.95 Million USD | 60.606% |
| Korro Bio, Inc. | 31.21 Million USD | -956.205% |
| Kineta, Inc. | 150 Thousand USD | -219703.333% |
| BioVie Inc. | 349.89 Thousand USD | -94129.967% |
| Codexis, Inc. | 12.24 Million USD | -2593.008% |
| Celularity Inc. | 26.17 Million USD | -1159.522% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -593.313% |
| Celcuity Inc. | 37.03 Million USD | -790.243% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -186865.891% |
| Cibus, Inc. | 17.67 Million USD | -1765.48% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -9657.473% |
| Kodiak Sciences Inc. | 100 Million USD | -229.705% |
| Annexon, Inc. | 29.19 Million USD | -1029.514% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -410.166% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -29285.472% |
| Avalo Therapeutics, Inc. | 2 Million USD | -16385.25% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 76.456% |
| Eyenovia, Inc. | 8.95 Million USD | -3580.881% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -402.147% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -3949.435% |
| Arcellx, Inc. | 50.84 Million USD | -548.502% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -22513.512% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -1452.43% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -31151.659% |
| Moolec Science SA | 99.04 Thousand USD | -332780.682% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -1093.675% |
| Geron Corporation | 35.05 Million USD | -840.644% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -55687.648% |
| Royalty Pharma plc | 6.13 Billion USD | 94.626% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -19979.476% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -1038602.665% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -1324.335% |
| Humacyte, Inc. | 38.6 Million USD | -754.158% |
| Structure Therapeutics Inc. | 4.01 Million USD | -8115.923% |
| 89bio, Inc. | 24.79 Million USD | -1229.724% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -2551.641% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -17569.078% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -31848.159% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -231.335% |
| Notable Labs, Ltd. | 1.52 Million USD | -21505.832% |
| Liquidia Corporation | 2.36 Million USD | -13846.912% |
| Mustang Bio, Inc. | 1.97 Million USD | -16568.605% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -2300.124% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -4641.91% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -103907.886% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -561.036% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -3332.997% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -503350.961% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -242330.147% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -5163.49% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -253519.231% |
| PepGen Inc. | 17.1 Million USD | -1828.099% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -69458.017% |
| United Therapeutics Corporation | 300 Million USD | -9.902% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -1277.156% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -7820.171% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -56942.388% |
| XOMA Corporation | 118.51 Million USD | -178.19% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -890994.595% |
| Bionomics Limited | 117.62 Million USD | -180.295% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -35238.156% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -5777.094% |
| uniQure N.V. | 130.06 Million USD | -153.492% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -462.733% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -47961.953% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -7502.144% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -23705.415% |
| Altimmune, Inc. | 175 Thousand USD | -188302.857% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 14.993% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -5777.094% |
| Compugen Ltd. | 719 Thousand USD | -45756.05% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -6408.192% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -289.93% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -3220.292% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -5068.6% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -260.688% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -3220.292% |
| Instil Bio, Inc. | 81.42 Million USD | -304.909% |
| argenx SE | 15.35 Million USD | -2047.356% |
| Immunome, Inc. | 1.34 Million USD | -24504.851% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -61412.127% |
| Verona Pharma plc | 48.37 Million USD | -581.575% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -3477.528% |
| Shattuck Labs, Inc. | 3.4 Million USD | -9580.123% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -387788.235% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -196152.976% |
| Moolec Science SA | 99.04 Thousand USD | -332780.682% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -2888.606% |
| AnaptysBio, Inc. | 16.03 Million USD | -1955.902% |
| Design Therapeutics, Inc. | 2.33 Million USD | -14026.178% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -1217826.933% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -5395.083% |
| Achilles Therapeutics plc | 1.07 Million USD | -30541.729% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -3477.528% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -1653717.215% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -1869.278% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -412929.589% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -4418945.704% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -2536092.308% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 3.731% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -1246.614% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -13088.253% |
| Palisade Bio, Inc. | 90 Thousand USD | -366238.889% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -169851.031% |
| Beam Therapeutics Inc. | 159.91 Million USD | -106.18% |
| Neurogene Inc. | 13.37 Million USD | -2365.453% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -7.599% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -1155.397% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -551043.392% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -32870.5% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -713.926% |
| Athira Pharma, Inc. | 1.21 Million USD | -26991.619% |
| Vaccinex, Inc. | 26 Thousand USD | -1267996.154% |
| HCW Biologics Inc. | 6.3 Million USD | -5129.828% |
| XOMA Corporation | 118.51 Million USD | -178.19% |
| Nektar Therapeutics | 112.62 Million USD | -192.746% |
| Arvinas, Inc. | 800 Thousand USD | -41113.125% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -2180.929% |
| Merus N.V. | 10.48 Million USD | -3043.64% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -2115.015% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -2355.172% |
| Rezolute, Inc. | 1.66 Million USD | -19761.747% |
| Clene Inc. | 7.15 Million USD | -4509.969% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -449407.826% |
| BeyondSpring Inc. | 3.36 Million USD | -9700.981% |
| Synlogic, Inc. | 12.49 Million USD | -2539.54% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -909.631% |
| Krystal Biotech, Inc. | 6.62 Million USD | -4880.438% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -92.901% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -5398.749% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -695905.995% |
| MannKind Corporation | 252.15 Million USD | -30.757% |
| Ikena Oncology, Inc. | 7.18 Million USD | -4491.992% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -165580.905% |
| Gossamer Bio, Inc. | 197.4 Million USD | -67.02% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -63304.808% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -17.196% |
| Mural Oncology plc | 8.91 Million USD | -3599.978% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -653.853% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -22859.958% |
| Champions Oncology, Inc. | 6.09 Million USD | -5311.21% |
| REGENXBIO Inc. | 82.22 Million USD | -300.994% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -66641.498% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -7335.837% |
| Vaxart, Inc. | 2.62 Million USD | -12469.767% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -121279.739% |
| Cellectis S.A. | 36.24 Million USD | -809.757% |
| Longeveron Inc. | 1.44 Million USD | -22669.682% |
| Repare Therapeutics Inc. | 1.01 Million USD | -32544.059% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 70.887% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -636.458% |
| Revolution Medicines, Inc. | 80.57 Million USD | -309.19% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -10177.587% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -186174.011% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -267952.846% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 54.505% |
| Denali Therapeutics Inc. | 44.98 Million USD | -632.987% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -2536.744% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -243946.958% |
| Passage Bio, Inc. | 22.92 Million USD | -1338.441% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -5359.596% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -50859.042% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -1535.036% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -67186.735% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -80817.741% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -27652.946% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -70652.146% |
| OmniAb, Inc. | 22.07 Million USD | -1393.567% |
| Anew Medical, Inc. | 1.54 Million USD | -21309.416% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -1015.376% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -3550.006% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -960.486% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -8032.31% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -539.496% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -5078.341% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2233.534% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -48963.244% |
| Alumis Inc. Common Stock | 30.86 Million USD | -968.39% |
| Equillium, Inc. | 384 Thousand USD | -85760.677% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -5253.223% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -118.277% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -574.533% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -273964.438% |
| Dominari Holdings Inc. | 3.02 Million USD | -10788.54% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -1667350.564% |
| vTv Therapeutics Inc. | 169 Thousand USD | -194991.716% |
| Bio-Techne Corporation | 319 Million USD | -3.356% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -478.552% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -84.64% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -2039.969% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -2562.562% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -6758.852% |
| Nkarta, Inc. | 82.27 Million USD | -300.76% |
| BioCardia, Inc. | 982 Thousand USD | -33474.847% |
| Iterum Therapeutics plc | 18.95 Million USD | -1639.317% |